Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
allo-APZ2-CVU in therapy‑resistant chronic venous ulcer
DRKS00026609Phase 2Completed
- Sponsor
- RHEACELL
- Start
- Sep 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of EBESANAR in venous stasis and stasis ulcer (4 arms), sponsored by RHEACELL. Started Sep 2021; status: completed.
02
Drugs
EBESANAR
03
Conditions
venous stasisstasis ulcer
Beyond the preview
Go deeper on DRKS00026609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00026609.